The COVID-19 Conundrum and Cancer – Making Perfect Sense of Imperfect Data

European Medical Journal Oncology

article

Utkarsh Acharya¹ 

[1] Department of Medical Oncology, Dana-Farber Cancer Institute;Department of Medical Oncology, Brigham and Women’s Hospital;Harvard Medical School

关键词: COVID;    COVID-19;    coronavirus;    SARS-Cov-2;    cancer;    immunotherapy;    cell therapy.;   

DOI  :  10.33590/emj/200518

学科分类：社会科学、人文和艺术（综合）

来源: European Medical Journal

【 摘 要 】

March 11th 2020 marked the day that the WorldHealth Organization (WHO) escalated thecoronavirus SARS-CoV-2 (COVID-19) outbreakfrom a public health emergency to a globalpandemic. Since first identified in December2019 in Wuhan, China, the confirmed cases ofCOVID-19 have reached a staggering 1,097,909,while claiming a total of 59,131 lives, at the time ofwriting.1 Of the numerous countries afflicted, theUSA is presently the worst affected with 276,995confirmed cases and expected logarithmicexpansion as widespread testing capabilitiestake traction.

【 授权许可】

CC BY-NC